Certified by Founder Lodge
OncoPep, Inc.
United States - Boston, Massachusetts
START UP
1 Disclosed Funding Rounds $11,000,000
0 Participating Investments
-
Founded date
2010
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Through targeting multiple tumor-associated antigens with an investigational multi-peptide vaccine and a multi-tumor antigen adoptive (MTAA) T cell therapy, OncoPep’s T cell focused technolog
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| December, 09 ,2021 | Series D | $11,000,000 |
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Sunthetics | $4,000,000 | (Nov 15, 2024)
Ecolectro | $10,500,000 | (Nov 15, 2024)
Workflow | $3,000,000 | (Nov 15, 2024)
Impilo | $11,500,000 | (Nov 15, 2024)
runQL | $1,600,000 | (Nov 15, 2024)
